Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01158183 · ClinicalTrials.gov registry record
Real-World Betaseron Health Economic Outcomes Study for Relapsing Forms of Multiple Sclerosis
A clinical trial, sponsored by Bayer.
- Completed
- Registry status
- 226
- Enrollment target
NCT01158183 is a clinical trial that has completed, run by Bayer. The registered enrollment target is 226 participants.
The verdict
NCT01158183 has completed, sponsored by Bayer.
- COMPLETED
- Registry status
- 226 participants
- Enrollment target
Study Summary
A Web based real world observational study in Relapsing-Remitting Multiple Sclerosis (RRMS) population capturing outcomes reported by patients and by the physicians during 12 months after initiating or resuming Betaseron.
Interventions
- DRUG BAY86-5046_Interferon-beta-1b
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 226 participants |
| Start Date | 2007-07 |
| Est. Completion | 2009-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01158183
The ClinicalTrials.gov registry entry for NCT01158183 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 226 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bayer, which has 591 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which BAY86-5046_Interferon-beta-1b is the first listed.
NCT01158183 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01158183 about?
NCT01158183 is a clinical study titled "Real-World Betaseron Health Economic Outcomes Study for Relapsing Forms of Multiple Sclerosis". A Web based real world observational study in Relapsing-Remitting Multiple Sclerosis (RRMS) population capturing outcomes reported by patients and by the physicians during 12 months after initiating or resuming Betaseron.
What is the current status of trial NCT01158183?
This trial is currently completed. The enrollment target is 226 participants. The study started on 2007-07. Estimated completion is 2009-09.
What interventions are being tested in trial NCT01158183?
The interventions under investigation include: BAY86-5046_Interferon-beta-1b (DRUG).
Who is sponsoring clinical trial NCT01158183?
This trial is sponsored by Bayer, which has 591 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.